It-terapija bid-dawl a\u0127mar qed ikollha t-tieni sajf virali tag\u0127ha. Dan ix-xahar, diversi postijiet b’aktar minn miljun share flimkien wieg\u0127du li pannell g\u0127ad-dar jista’ ire\u0121\u0121a’ lura t-tixji\u0127 vi\u017cibbli tal-\u0121ilda, jer\u0121a’ ikabbar ix-xag\u0127ar, isa\u0127\u0127a\u0127 il-mo\u0127\u0127, i\u0127affef l-irkupru tal-muskoli u anke jirrestawra l-vi\u017cjoni li qed tixjie\u0127. Xi w\u0127ud minn dawn il-postijiet jikkwotaw IDs ta’ PubMed, li jag\u0127milhom jidhru b\u0127ala xjenza. O\u0127rajn isostnu li studju kliniku \u201cre\u0121\u0121a’ lura s-sinjali kollha tat-tixji\u0127 u l-mard\u201d. L-interess fit-tfittxija rdoppja f’sentejn, u ji\u017cdied kull \u0127arifa.<\/p>\n
Jiena nu\u017ca d-dawl fil-prattika tieg\u0127i kull \u0121img\u0127a, inklu\u017ci lasers frazzjonali u mhux ablattivi<\/a>. G\u0127alhekk qrajt id-dokumenti li fuqhom huma mibnija l-postijiet. Hawnhekk hawn dak li jg\u0127idu fil-fatt.<\/p>\n Il-kun\u010bett \u017cbaljat mhuwiex li d-dawl a\u0127mar ma jag\u0127mel xejn. Huwa jag\u0127mel xi \u0127a\u0121a. Il-kun\u010bett \u017cbaljat huwa li n-numri fil-postijiet jiddeskrivu dak li pannell mixtri online se jag\u0127mel lil wi\u010b\u010bek fil-kamra tal-banju tieg\u0127ek.<\/p>\n \u201c36% inqas tikmix, 19% aktar elasti\u010bit\u00e0.\u201d<\/strong> Dan \u0121ej minn prova Koreana tal-2007 fuq 76 pazjent. Kien studju xieraq randomised u split-face, u tabil\u0127aqq sab titjib fit-tikmix u fl-elasti\u010bit\u00e0. Tliet dettalji huma neqsin mill-postijiet. L-ewwel, i\u010b-\u010bifri huma l-valuri massimi rre\u0121istrati, mhux il-medja. It-tieni, l-apparati kienu unitajiet LED ta’ grad kliniku u\u017cati f’ambjent ta’ studju darbtejn fil-\u0121img\u0127a, mhux pannell mixtri online. It-tielet, is-segwitu kien ta’ tliet xhur. \u0126add ma kejjel x’\u0121ara wara dak i\u017c-\u017cmien.<\/p>\n \u201c37% aktar tkabbir tax-xag\u0127ar.\u201d<\/strong> Din hija prova tal-2014 fuq 47 mara b’telf ta’ xag\u0127ar tat-tip pattern, li 42 minnhom temmew l-istudju. Elmu b’dijodi tal-laser u LEDs intlibes kull jumejn g\u0127al 16-il \u0121img\u0127a. L-g\u0127add ta’ xag\u0127ar f’bi\u010b\u010ba \u017cg\u0127ira tat-tatuwa\u0121\u0121 fuq il-qorrieg\u0127a \u017cdied b’madwar 48% fil-grupp attiv u 11% fil-grupp tal-placebo; i\u010b-\u010bifra ta’ 37% hija d-differenza bejn it-tnejn. Ir-ri\u017cultat huwa reali u huwa g\u0127alhekk li nie\u0127u d-dawl ta’ livell baxx bis-serjet\u00e0 g\u0127ax-xag\u0127ar. I\u017cda \u201caktar xag\u0127ar\u201d hawnhekk tfisser aktar xag\u0127ar mag\u0127dud f’bi\u010b\u010ba ta’ 2.85 \u010bentimetru kwadru, mhux hairline restawrata b’mod vi\u017cibbli.<\/p>\n \u201c22% vi\u017cjoni a\u0127jar tal-kuntrast tal-kulur.\u201d<\/strong> Dan huwa studju tal-2020 minn istitut tal-oftalmolo\u0121ija f’Londra li fih 24 persuna \u0127arsu lejn dawl ta’ 670 nm g\u0127al tliet minuti kuljum g\u0127al \u0121imag\u0127tejn. It-titjib deher biss f’parte\u010bipanti ta’ aktar minn madwar 40 sena, prin\u010bipalment fl-assi blu tal-vi\u017cjoni tal-kulur, b’titjib i\u017cg\u0127ar fis-sensittivit\u00e0 tar-rods f’dawl baxx. Il-fra\u017ci tal-post \u201crestawrat il-funzjoni vi\u017cwali lejn livelli i\u017cg\u0127ar\u201d hija l-fra\u017ci tal-post, mhux tad-dokument xjentifiku.<\/p>\n \u201cKonjizzjoni u newroplasti\u010bit\u00e0 aktar qawwija.\u201d<\/strong> Il-prova kkwotata tal-2024 irre\u0121istrat 93 adult anzjan li di\u0121\u00e0 kellhom indeboliment konjittiv \u0127afif, mhux adulti b’sa\u0127\u0127ithom ta’ aktar minn 50 sena. Id-dawl kien qrib l-infra-a\u0127mar mog\u0127ti permezz tal-qorrieg\u0127a ta\u0127t kundizzjonijiet ta’ studju, b’grupp ta’ placebo. Il-punte\u0121\u0121i tal-konjizzjoni tjiebu b’madwar punt wie\u0127ed aktar mill-placebo fuq skala ta’ 30 punt. Dak huwa sejba ta’ ri\u010berka sinifikanti g\u0127al kundizzjoni medika. Mhuwiex ri\u017cultat ta’ benesseri fid-dar.<\/p>\n \u201cIrkupru tal-muskoli aktar mg\u0127a\u0121\u0121el.\u201d<\/strong> Id-dokument ikkwotat huwa meta-anali\u017ci tal-2023. Huwa sab benefi\u010b\u010bju g\u0127all-irkupru mill-g\u0127eja u l-ebda benefi\u010b\u010bju g\u0127as-sa\u0127\u0127a jew il-kapa\u010bit\u00e0 funzjonali. Il-postijiet i\u017commu biss l-ewwel nofs.<\/p>\n \u201cJintera\u0121ixxi mal-mitokondrija biex i\u017cid l-ATP.\u201d<\/strong> Dan il-mekkani\u017cmu huwa deskritt tajjeb. L-aktar dokument ikkwotat g\u0127alih, mill-2004, sar fuq newroni tal-firien f’dixx esposti g\u0127a\u010b-\u010bjanur. Huwa jispjega kif id-dawl jista’ ja\u0127dem. Ma jg\u0127idlekx x’jag\u0127mel pannell lil wi\u010b\u010b il-bniedem.<\/p>\n \u201cRe\u0121\u0121a’ lura s-sinjali kollha tat-tixji\u0127 u l-mard b’dawl ta’ 620 nm, 12-il minuta darbtejn fil-\u0121img\u0127a.\u201d<\/strong> Dan l-istudju je\u017cisti, u ta’ min wie\u0127ed jaqrah mill-qrib. Huwa studju tal-2023 ta’ 20 voluntier im\u0127allsa ta’ bejn il-45 u s-70 sena, \u0127mistax-il mara u \u0127ames ir\u0121iel, li u\u017caw maskra LED ta’ 630 nm (mhux 620) id-dar g\u0127al 12-il minuta, darbtejn fil-\u0121img\u0127a, g\u0127al tliet xhur. Il-fond tal-crow’s feet naqas b’madwar terz, u l-fermezza u d-densit\u00e0 dermali tjiebu; il-kejl baqa’ stabbli g\u0127al xahar wara li waqfu. Tliet affarijiet li l-post i\u0127alli barra: ma kien hemm l-ebda grupp ta’ placebo, il-parte\u010bipanti baqg\u0127u ju\u017caw il-kura tal-\u0121ilda tas-soltu tag\u0127hom matul il-pro\u010bess kollu, u d-dokument kien miktub mill-kumpanija tal-ko\u017cmeti\u010bi li tbig\u0127 il-maskra flimkien mal-manifattur tal-LED, li l-kap e\u017cekuttiv tieg\u0127u huwa ko-awtur. Xejn fih ma jikkon\u010berna l- \u201cmard\u201d. Huwa studju ta’ prodott de\u010benti; mhuwiex prova klinika. Dettall wie\u0127ed utli mid-dokument: l-awturi \u0127allew 72 sieg\u0127a bejn is-sessjonijiet apposta, g\u0127aliex l-u\u017cu ta’ kuljum ma ja\u0127dimx a\u0127jar. Aktar mhux bilfors ifisser a\u0127jar.<\/p>\n G\u0127al tqabbil, studju ppubblikat f’\u0120unju ta’ din is-sena \u0127ares lejn laser frazzjonali mhux ablattiv ta’ 1940 nm, it-tip ta’ apparat li jinsab fi klinika u mhux f’kamra tas-sodda. Tnejn u g\u0127oxrin adult kellhom tliet trattamenti, xahar ‘il bog\u0127od minn xulxin, fuq na\u0127a wa\u0127da tal-wi\u010b\u010b. It-tikek kannella fuq in-na\u0127a ttrattata naqsu b’madwar 38% wara xahar. Sa sitt xhur it-titjib vi\u017cibbli kien naqas u ma kienx g\u0127adu statistikament sinifikanti, i\u017cda l-mudell tal-metilazzjoni tad-DNA tal-\u0121ilda ttrattata kien inbidel mill-mudell tal-\u0121ilda li qed tixjie\u0127 u baqa’ mibdul.<\/p>\n Tliet noti onesti. L-istudju kien miktub mit-tim ta’ ri\u010berka tal-manifattur stess; 22 persuna huma grupp \u017cg\u0127ir; u g\u0127axra biss minnhom re\u0121g\u0127u \u0121ew g\u0127a\u017c-\u017cjara ta’ sitt xhur. L-awturi stess jg\u0127idu li l-kelma \u201crejuvenation\u201d fid-dokument tag\u0127hom ma tfissirx li qed ire\u0121\u0121g\u0127u lura l-et\u00e0 bijolo\u0121ika. Dak li jag\u0127mlu ri\u017cultat serju huwa l-forma tieg\u0127u: apparat b’bi\u017c\u017cejjed ener\u0121ija biex iwe\u0121\u0121a’ d-dermis b’mod ikkontrollat, rispons ta’ fejqan tal-feriti, u bidla molekulari mkejla kontra n-na\u0127a mhux ittrattata tal-pazjent stess. Il-pannelli LED tad-dar ma jag\u0127tux dik l-ener\u0121ija. Dak huwa l-g\u0127an tag\u0127hom. Huma sikuri pre\u010bi\u017cament g\u0127ax huma dg\u0127ajfa.<\/p>\n It-terapija bid-dawl a\u0127mar hija drawwa ra\u0121onevoli u ta’ riskju baxx g\u0127al tliet affarijiet: titjib \u0127afif fin-nis\u0121a tal-\u0121ilda u linji fini, appo\u0121\u0121 g\u0127al telf ta’ xag\u0127ar bikri flimkien ma’ trattament mediku, u rkupru wara l-e\u017cer\u010bizzju. Stenna bidla modesta, stenna li jkollha b\u017conn xhur ta’ u\u017cu konsistenti, u stenna li tonqos fi \u017cmien \u0121img\u0127at wara li tieqaf.<\/p>\n Mhux se tg\u0127olli l-jowl, tissikka l-g\u0127onq, tne\u0127\u0127i l-\u0127sara mix-xemx, jew tissostitwixxi trapjant tax-xag\u0127ar. Ir-ritratti ta’ qabel u wara li ji\u010b\u010birkolaw normalment jittie\u0127du f’erba’ sa tmien \u0121img\u0127at, li huwa meta kwalunkwe trattament tal-wi\u010b\u010b jidher fl-aqwa tieg\u0127u<\/a>. In-nef\u0127a tiffavorixxi lil kul\u0127add. I\u0121\u0121udika kwalunkwe trattament bid-dawl, inklu\u017c tieg\u0127i, wara sitt xhur.<\/p>\n Jekk qed tag\u0127\u017cel apparat, fittex il-wavelengths li l-istudji t’hawn fuq fil-fatt u\u017caw: 630 sa 660 nm g\u0127all-\u0121ilda, 655 nm g\u0127ax-xag\u0127ar, bi 830 nm mi\u017cjuda fil-prova tal-\u0121ilda. Irradjanza ddikjarata u \u0127in ta’ trattament iddikjarat huma aktar importanti mid-daqs tal-pannell. Ilbes il-protezzjoni g\u0127all-g\u0127ajnejn li ti\u0121i mieg\u0127u.<\/p>\n Jiena nmexxi protokolli tal-laser u nibbenefika meta l-pazjenti jag\u0127\u017cluhom. Aqra x-xetti\u010bi\u017cmu tieg\u0127i dwar il-pannelli tad-dar b’dan f’mo\u0127\u0127ok. Il-kontro-argument huwa \u0121ust: pannell tad-dar jiswa frazzjoni ta’ kors fi klinika u ma j\u0121orr kwa\u017ci l-ebda riskju, u g\u0127al xi \u0127add fit-tletinijiet tieg\u0127u b’bidliet bikrija jista’ jkun bi\u017c\u017cejjed g\u0127al ftit snin.<\/p>\n Il-limitu l-ie\u0127or huwa l-ba\u017ci tal-evidenza stess. Il-bi\u010b\u010ba l-kbira tal-provi tad-dawl a\u0127mar huma \u017cg\u0127ar, qosra, u mmexxija minn nies li jag\u0127mlu jew ibig\u0127u l-apparati. Dan huwa minnu wkoll g\u0127all-istudju tal-laser li fa\u0127\u0127art hawn fuq. Il-po\u017cizzjoni onesta hija li l-fotobijomodulazzjoni ta\u0127dem fil-livell \u010bellulari, tipprodu\u010bi titjib \u017cg\u0127ir li jista’ jitkejjel fil-\u0121ilda u fix-xag\u0127ar f’ambjenti kkontrollati, u qed tinbieg\u0127 fuq il-midja so\u010bjali b\u0127ala \u0127afna aktar minn hekk.<\/p>\n Jekk trid tkun taf jekk dawl ta’ kwalunkwe tip huwiex il-pass li jmiss it-tajjeb g\u0127al wi\u010b\u010bek jew il-qorrieg\u0127a tieg\u0127ek, ibg\u0127at ritratt u l-mistoqsija tieg\u0127ek lil +90 544 772 0772<\/a>. Twe\u0121iba onesta ma tiswa xejn.<\/p>\n Dr. Mustafa Ayd\u0131nol huwa kirurgu plastik, rikostruttiv u estetiku f’Istanbul u membru tal-ISAPS.<\/em><\/p>\n Il-postijiet virali dwar id-dawl a\u0127mar jikkwotaw studji reali. Dak li fil-verit\u00e0 kejlu dawk l-istudji, x’jista’ u ma jistax jag\u0127mel pannell g\u0127ad-dar, u fejn jibdew il-lasers tal-klinika.<\/p>\n","protected":false},"author":3,"featured_media":33096,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2677],"tags":[],"class_list":["post-33143","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-opinjoni-esperta"],"yoast_head":"\nIl-kun\u010bett \u017cbaljat komuni<\/h2>\n
Ir-realt\u00e0 klinika: l-istudji wara n-numri<\/h2>\n
Kif jidher studju reali dwar id-dawl<\/h2>\n
Il-konklu\u017cjoni prattika g\u0127all-pazjenti<\/h2>\n
Limiti onesti<\/h2>\n
Sorsi<\/h2>\n
\n